{"count": 18, "results": [{"_id": "37373251", "pmid": 37373251, "pmcid": "PMC10298641", "title": "Changes in the Subchondral Bone, Visfatin, and Cartilage Biomarkers after Pharmacological Treatment of Experimental Osteoarthritis with Metformin and Alendronate", "journal": "Int J Mol Sci", "authors": ["Lambova SN", "Ivanovska N", "Stoyanova S", "Belenska-Todorova L", "Georgieva E", "Batsalova T", "Moten D", "Apostolova D", "Dzhambazov B"], "date": "2023-06-14T00:00:00Z", "doi": "10.3390/ijms241210103", "meta_date_publication": "2023 Jun 14", "meta_volume": "24", "meta_issue": "12", "meta_pages": "", "score": 50276.164, "text_hl": "In addition, treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Alendronate @CHEMICAL_MESH:D019386 @@@alendronate@@@ as a monotherapy, or their combination lowered the level of some @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage@@@ biomarkers (CTX-II and @GENE_COMP @GENE_12845 @@@COMP@@@). ", "citations": {"NLM": "Lambova SN, Ivanovska N, Stoyanova S, Belenska-Todorova L, Georgieva E, Batsalova T, Moten D, Apostolova D, Dzhambazov B. Changes in the Subchondral Bone, Visfatin, and Cartilage Biomarkers after Pharmacological Treatment of Experimental Osteoarthritis with Metformin and Alendronate Int J Mol Sci. 2023 Jun 14;24(12):. PMID: 37373251", "BibTeX": "@article{37373251, title={Changes in the Subchondral Bone, Visfatin, and Cartilage Biomarkers after Pharmacological Treatment of Experimental Osteoarthritis with Metformin and Alendronate}, author={Lambova SN and Ivanovska N and Stoyanova S and Belenska-Todorova L and Georgieva E and Batsalova T and Moten D and Apostolova D and Dzhambazov B}, journal={Int J Mol Sci}, volume={24}, number={12}}"}}, {"_id": "33808727", "pmid": 33808727, "pmcid": "PMC8003384", "title": "Metformin Attenuates Monosodium-Iodoacetate-Induced Osteoarthritis via Regulation of Pain Mediators and the Autophagy-Lysosomal Pathway", "journal": "Cells", "authors": ["Na HS", "Kwon JY", "Lee SY", "Lee SH", "Lee AR", "Woo JS", "Jung K", "Cho KH", "Choi JW", "Lee DH", "Min HK", "Park SH", "Kim SJ", "Cho ML"], "date": "2021-03-19T00:00:00Z", "doi": "10.3390/cells10030681", "meta_date_publication": "2021 Mar 19", "meta_volume": "10", "meta_issue": "3", "meta_pages": "", "score": 50271.91, "text_hl": "The combined administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Celecoxib @CHEMICAL_MESH:D000068579 @@@celecoxib@@@ controlled @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage damage@@@ more effectively than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone. ", "citations": {"NLM": "Na HS, Kwon JY, Lee SY, Lee SH, Lee AR, Woo JS, Jung K, Cho KH, Choi JW, Lee DH, Min HK, Park SH, Kim SJ, Cho ML. Metformin Attenuates Monosodium-Iodoacetate-Induced Osteoarthritis via Regulation of Pain Mediators and the Autophagy-Lysosomal Pathway Cells. 2021 Mar 19;10(3):. PMID: 33808727", "BibTeX": "@article{33808727, title={Metformin Attenuates Monosodium-Iodoacetate-Induced Osteoarthritis via Regulation of Pain Mediators and the Autophagy-Lysosomal Pathway}, author={Na HS and Kwon JY and Lee SY and Lee SH and Lee AR and Woo JS and Jung K and Cho KH and Choi JW and Lee DH and Min HK and Park SH and Kim SJ and Cho ML}, journal={Cells}, volume={10}, number={3}}"}}, {"_id": "34440221", "pmid": 34440221, "pmcid": "PMC8391621", "title": "Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis", "journal": "Biomedicines", "authors": ["Belenska-Todorova L", "Lambova SN", "Stoyanova S", "Georgieva E", "Batsalova T", "Moten D", "Kolchakova D", "Dzhambazov B"], "date": "2021-08-15T00:00:00Z", "doi": "10.3390/biomedicines9081017", "meta_date_publication": "2021 Aug 15", "meta_volume": "9", "meta_issue": "8", "meta_pages": "", "score": 50270.086, "text_hl": "In addition, taking in account the histological analyses, we found that the combination of @CHEMICAL_Alendronate @CHEMICAL_MESH:D019386 @@@alendronate@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may protect @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage destruction@@@ that occurs during @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@. ", "citations": {"NLM": "Belenska-Todorova L, Lambova SN, Stoyanova S, Georgieva E, Batsalova T, Moten D, Kolchakova D, Dzhambazov B. Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis Biomedicines. 2021 Aug 15;9(8):. PMID: 34440221", "BibTeX": "@article{34440221, title={Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis}, author={Belenska-Todorova L and Lambova SN and Stoyanova S and Georgieva E and Batsalova T and Moten D and Kolchakova D and Dzhambazov B}, journal={Biomedicines}, volume={9}, number={8}}"}}, {"_id": "32087740", "pmid": 32087740, "pmcid": "PMC7036179", "title": "Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior", "journal": "Arthritis Res Ther", "authors": ["Li H", "Ding X", "Terkeltaub R", "Lin H", "Zhang Y", "Zhou B", "He K", "Li K", "Liu Z", "Wei J", "Yang Y", "Xie H", "Zeng C", "Lei G"], "date": "2020-02-22T00:00:00Z", "doi": "10.1186/s13075-020-2129-y", "meta_date_publication": "2020 Feb 22", "meta_volume": "22", "meta_issue": "1", "meta_pages": "34", "score": 50266.27, "text_hl": "Exploration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as novel therapy for @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@osteoarthritis@@@: preventing @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage degeneration@@@ and reducing @DISEASE_Pain @DISEASE_MESH:D010146 @@@pain@@@ behavior", "citations": {"NLM": "Li H, Ding X, Terkeltaub R, Lin H, Zhang Y, Zhou B, He K, Li K, Liu Z, Wei J, Yang Y, Xie H, Zeng C, Lei G. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior Arthritis Res Ther. 2020 Feb 22;22(1):34. PMID: 32087740", "BibTeX": "@article{32087740, title={Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior}, author={Li H and Ding X and Terkeltaub R and Lin H and Zhang Y and Zhou B and He K and Li K and Liu Z and Wei J and Yang Y and Xie H and Zeng C and Lei G}, journal={Arthritis Res Ther}, volume={22}, number={1}, pages={34}}"}}, {"_id": "36982442", "pmid": 36982442, "pmcid": "PMC10049635", "title": "Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis", "journal": "Int J Mol Sci", "authors": ["Zheng M", "Zhu Y", "Wei K", "Pu H", "Peng R", "Xiao J", "Liu C", "Sun X"], "date": "2023-03-10T00:00:00Z", "doi": "10.3390/ijms24065355", "meta_date_publication": "2023 Mar 10", "meta_volume": "24", "meta_issue": "6", "meta_pages": "", "score": 50263.133, "text_hl": "However, how @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ attenuates @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage degeneration@@@ is not clear. ", "citations": {"NLM": "Zheng M, Zhu Y, Wei K, Pu H, Peng R, Xiao J, Liu C, Sun X. Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis Int J Mol Sci. 2023 Mar 10;24(6):. PMID: 36982442", "BibTeX": "@article{36982442, title={Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis}, author={Zheng M and Zhu Y and Wei K and Pu H and Peng R and Xiao J and Liu C and Sun X}, journal={Int J Mol Sci}, volume={24}, number={6}}"}}, {"_id": "31945013", "pmid": 31945013, "pmcid": "PMC7053618", "title": "Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR", "journal": "Aging (Albany NY)", "authors": ["Feng X", "Pan J", "Li J", "Zeng C", "Qi W", "Shao Y", "Liu X", "Liu L", "Xiao G", "Zhang H", "Bai X", "Cai D"], "date": "2020-01-16T00:00:00Z", "doi": "10.18632/aging.102635", "meta_date_publication": "2020 Jan 16", "meta_volume": "12", "meta_issue": "2", "meta_pages": "1087-1103", "score": 50259.04, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage degeneration@@@ in DMM @SPECIES_10090 @@@mice@@@ and cartilage explants", "citations": {"NLM": "Feng X, Pan J, Li J, Zeng C, Qi W, Shao Y, Liu X, Liu L, Xiao G, Zhang H, Bai X, Cai D. Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR Aging (Albany NY). 2020 Jan 16;12(2):1087-1103. PMID: 31945013", "BibTeX": "@article{31945013, title={Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR}, author={Feng X and Pan J and Li J and Zeng C and Qi W and Shao Y and Liu X and Liu L and Xiao G and Zhang H and Bai X and Cai D}, journal={Aging (Albany NY)}, volume={12}, number={2}, pages={1087-1103}}"}}, {"_id": "32792951", "pmid": 32792951, "pmcid": "PMC7393141", "title": "Metformin Mitigates Cartilage Degradation by Activating AMPK/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model", "journal": "Front Pharmacol", "authors": ["Wang C", "Yao Z", "Zhang Y", "Yang Y", "Liu J", "Shi Y", "Zhang C"], "date": "2020-07-24T00:00:00Z", "doi": "10.3389/fphar.2020.01114", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "1114", "score": 50257.547, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Attenuates @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@Cartilage@@@ Degradation in @SPECIES_10090 @@@Mice@@@ With @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@", "citations": {"NLM": "Wang C, Yao Z, Zhang Y, Yang Y, Liu J, Shi Y, Zhang C. Metformin Mitigates Cartilage Degradation by Activating AMPK/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model Front Pharmacol. 2020;11():1114. PMID: 32792951", "BibTeX": "@article{32792951, title={Metformin Mitigates Cartilage Degradation by Activating AMPK/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model}, author={Wang C and Yao Z and Zhang Y and Yang Y and Liu J and Shi Y and Zhang C}, journal={Front Pharmacol}, volume={11}, pages={1114}}"}}, {"_id": "32156705", "pmid": 32156705, "pmcid": "PMC7213329", "title": "Metformin limits osteoarthritis development and progression through activation of AMPK signalling", "journal": "Ann Rheum Dis", "authors": ["Li J", "Zhang B", "Liu WX", "Lu K", "Pan H", "Wang T", "Oh CD", "Yi D", "Huang J", "Zhao L", "Ning G", "Xing C", "Xiao G", "Liu-Bryan R", "Feng S", "Chen D"], "date": "2020-05-01T00:00:00Z", "doi": "10.1136/annrheumdis-2019-216713", "meta_date_publication": "2020 May", "meta_volume": "79", "meta_issue": "5", "meta_pages": "635-645", "score": 50255.605, "text_hl": "The administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, commencing either before or after DMM surgery, caused significant reduction in @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage degradation@@@. ", "citations": {"NLM": "Li J, Zhang B, Liu WX, Lu K, Pan H, Wang T, Oh CD, Yi D, Huang J, Zhao L, Ning G, Xing C, Xiao G, Liu-Bryan R, Feng S, Chen D. Metformin limits osteoarthritis development and progression through activation of AMPK signalling Ann Rheum Dis. 2020 May;79(5):635-645. PMID: 32156705", "BibTeX": "@article{32156705, title={Metformin limits osteoarthritis development and progression through activation of AMPK signalling}, author={Li J and Zhang B and Liu WX and Lu K and Pan H and Wang T and Oh CD and Yi D and Huang J and Zhao L and Ning G and Xing C and Xiao G and Liu-Bryan R and Feng S and Chen D}, journal={Ann Rheum Dis}, volume={79}, number={5}, pages={635-645}}"}}, {"_id": "32404018", "pmid": 32404018, "title": "Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats.", "journal": "Ultrastruct Pathol", "authors": ["Dawood AF", "Alzamil N", "Ebrahim HA", "Abdel Kader DH", "Kamar SS", "Haidara MA", "Al-Ani B"], "date": "2020-05-03T00:00:00Z", "doi": "10.1080/01913123.2020.1762815", "meta_date_publication": "2020 May 3", "meta_volume": "44", "meta_issue": "3", "meta_pages": "273-282", "score": 50253.043, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ pretreatment suppresses alterations to the articular @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage@@@ ultrastructure and @DISEASE_Knee_Injuries @DISEASE_MESH:D007718 @@@knee joint tissue damage@@@ secondary to @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Dawood AF, Alzamil N, Ebrahim HA, Abdel Kader DH, Kamar SS, Haidara MA, Al-Ani B. Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats. Ultrastruct Pathol. 2020 May 3;44(3):273-282. PMID: 32404018", "BibTeX": "@article{32404018, title={Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats.}, author={Dawood AF and Alzamil N and Ebrahim HA and Abdel Kader DH and Kamar SS and Haidara MA and Al-Ani B}, journal={Ultrastruct Pathol}, volume={44}, number={3}, pages={273-282}}"}}, {"_id": "32334102", "pmid": 32334102, "title": "Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis.", "journal": "Nanomedicine", "authors": ["He Y", "Ren E", "Lu Z", "Chen H", "Qin Z", "Wang J", "He M", "Liu G", "Zheng L", "Zhao J"], "date": "2020-08-01T00:00:00Z", "doi": "10.1016/j.nano.2020.102210", "meta_date_publication": "2020 Aug", "meta_volume": "28", "meta_issue": "", "meta_pages": "102210", "score": 50251.773, "text_hl": "It demonstrated that the CT-Fn/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ could specifically bind to type II collagen, leading to the downregulation of catabolic markers of @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@ and promotion of @<m>DISEASE_Cartilage_Diseases</m> @DISEASE_MESH:D002357 @@@cartilage@@@-specific makers in @GENE_IL1B @GENE_3553 @@@IL-1beta@@@-induced chondrocytes. ", "citations": {"NLM": "He Y, Ren E, Lu Z, Chen H, Qin Z, Wang J, He M, Liu G, Zheng L, Zhao J. Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis. Nanomedicine. 2020 Aug;28():102210. PMID: 32334102", "BibTeX": "@article{32334102, title={Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis.}, author={He Y and Ren E and Lu Z and Chen H and Qin Z and Wang J and He M and Liu G and Zheng L and Zhao J}, journal={Nanomedicine}, volume={28}, pages={102210}}"}}]}